Some investigators have shown that the TS expression in gastric cancer is of limited value in predicting the clinical response to fluoropyrimidine-based chemotherapy (Boku et al, 1998; Miyamoto et al, 2000). The gene discussed is TYMS; the disease is gastric cancer.